Marijuana to Stay A Schedule I Drug, Federal Judge Denies Reclassification

Image result for alexis bortell

By Anushree Madappa On 02/27/18

On Monday, a federal judge of the U.S. District Court for the Southern District of New York dismissed a request to reclassify marijuana — currently a Schedule I drug, leaving the plaintiffs in a limbo after many states have legalized marijuana for medical and recreational purposes.

The plaintiffs — Marvin Washington, Dean Bartell, Alexis Bartell, Jose Belen, Sebastien Cotte, Jagger Cotte, along with the Cannabis Cultural Association Inc. — filed the petition challenging classification of marijuana as a Schedule I drug, hoping that it’s reclassification would pay way for legalization of cannabis across the nation. They sued Attorney General Jeff Sessions, the Department of Justice and the Drug Enforcement Administration (DEA) in the federal court.

They petitioners claimed that the “current scheduling of marijuana violates due process because it lacks a rational basis.”

For decades, Marijuana has been under the Schedule I category of the Controlled Substances Act, the highest level of drug classification making it on par with dangerous drugs like heroin. The government has repeatedly rejected appeals for reclassification. The substances in this schedule have “a high potential for abuse,” (2) “no currently accepted medical use in treatment in the United States,” and (3) there is “a lack of accepted safety for use of the drug or other substance under medical supervision.”

Deeming marijuana as a highly dangerous drug, the U.S. Congress proffered the power to reclassify the drug with the attorney general. The power to reclassify was also granted to the Drug Enforcement Agency (DEA), provided the attorney general signs off on the petition to reclassify the drug based on medical and scientific data provided by the Department of Health and Human Services (HHS). The data should be consistent with the argument for reclassification.

While dismissing the petition, which argued that there was no “rational basis” for the Congress to classify Marijuana under Schedule I, Judge Alkin K Hellerstein said, “By framing their claim in terms of the statutory factors outlined in Section 8 l 2(b) (1), plaintiffs’ lawsuit is best understood as a collateral attack on the various administrative determinations not to reclassify marijuana into a different drug schedule.”

“As such, plaintiffs’ claim is barred because plaintiffs failed to exhaust their administrative remedies,” he added.

The “exhaustion rule” generally implies the plaintiffs to go through all parties and exhaust all “administrative remedies” before moving to the federal courts, which the judge found was not followed in the case.

By approaching the federal court, the petitioners chose to avoid the same fate dealt to previous complaints that challenged the administration agency and lost in 2016, the judge said.

In 2016, a request to reclassify marijuana was denied by the DEA. In a letter to the petitioners, the agency said, “HHS concluded that marijuana has a high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision.”

The federal court judge said he agrees with the previous verdict given by Judge Wolford of the Western District of New York in the United States v. Green case where he said the petition did not challenge the DEA’s decision “to conclude that there is no currently accepted medical use for marijuana” but the constitutional issue is “whether there is any conceivable basis to support the placement of marijuana on the most stringent schedule under the [Controlled Substance Act] CSA.”

In a document stating the verdict, Hellerstein said, “Plaintiffs have failed to state a claim under any constitutional theory, all of plaintiffs’ remaining claims are also dismissed.”

The judge concluded that the “defendants’ motion to dismiss the complaint is granted. Plaintiffs have already amended their complaint once, and I find that further amendments would be futile.”

CONTINUE READING…

RELATED:

Alexis Bortell, 12, Won’t Let Court Loss Stop Jeff Sessions Medical Pot Fight  (1-27-18)

Last year, then-eleven-year-old Colorado resident and medical marijuana patient Alexis Bortell joined other plaintiffs in a lawsuit against pot-hating Attorney General Jeff Sessions over federal scheduling of cannabis. Yesterday, February 26, a judge with the U.S. District Court for the Southern District of New York dismissed the suit, but Bortell, now twelve, wasn’t distressed. Shortly after the news went public, a post appeared on her Facebook page reading, “We were ready. Smile. We know #SCOTUS [Supreme Court of the United States] is where we are probably going.”   LINK

The note ended with the hashtags #IStandWithAlexis and #AlexisBortell.

http://floridamarijuana.net/breaking-news-jeff-sessions-dea-stand-trial-federal-lawsuit-de-schedule-cannabis/

Advertisements

Wayward Bill attends the 2017 Cannabis Business Awards, Alexis Bortell wins “Most Influential” 2017!

No automatic alt text available.

The Cannabis Business Awards 2017 Presented by Chloe Villano and Clover Leaf

There were many valuable and appreciated Activists who were represented at the Cannabis Business Awards in Denver, Colorado last night.

The Cannabis Business Awards features industry power players including CEO and Founder Chloe Villano, an entrepreneur featured in People Magazine’s “Marijuana Millionaires.” As one of the first and most sought-after consultants in the industry, Villano was the first executive to receive full accredited approval from the Department of Higher Education for her cannabis school Clover Leaf University. LINK

Image may contain: 1 person, smiling, sitting

Undoubtedly the Star of the show was Alexis Bortell, who won “Most Influential Individual” for 2017.  Alexis is suing General Jeff Sessions “not for money but for freedom”!  You can view the video of her acceptance at this LINK.

alexis bortell 12.7.17

The suit aims to prove that the Controlled Substances Act, the statute governing federal drug policy, is unconstitutional as it relates to marijuana, according to Alexis’ attorney, Michael S. Hiller.   LINK

In 2016 Wayward Bill won the Lifetime Achievement Award and has attended and participated in each yearly event since it began in 2012.  The following pictures he gathered while attending last nights ceremony.

WB 00

WB1

WB 2

WB 3

GOOGLE SEARCH FOR ALEXIS BORTELL HERE

FOLLOW CHLOE VILLANO ON FACEBOOK FOR UPDATED INFORMATION!